Your browser doesn't support javascript.
loading
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer.
Choughule, A; Sharma, R; Trivedi, V; Thavamani, A; Noronha, V; Joshi, A; Desai, S; Chandrani, P; Sundaram, P; Utture, S; Jambhekar, N; Gupta, S; Aich, J; Prabhash, K; Dutt, A.
Affiliation
  • Choughule A; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Sharma R; 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Trivedi V; 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Thavamani A; 1] Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India [2] Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Desai S; Department of Pathology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Chandrani P; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Sundaram P; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Utture S; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Jambhekar N; Department of Pathology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Gupta S; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Aich J; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Center, Mumbai, India.
  • Dutt A; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Center, Navi Mumbai, India.
Br J Cancer ; 111(11): 2203-4, 2014 Nov 25.
Article in En | MEDLINE | ID: mdl-25117816
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Ras Proteins / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2014 Document type: Article Affiliation country: India Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Proto-Oncogene Proteins / Carcinoma, Non-Small-Cell Lung / Ras Proteins / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms / Mutation Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2014 Document type: Article Affiliation country: India Country of publication: Reino Unido